202 results on '"Wikman, H"'
Search Results
2. A novel microfluidic platform for size and deformability based separation and the subsequent molecular characterization of viable circulating tumor cells
3. P02.01 A strategy to personalize the use of radiation in patients with brain metastasis based on S100A9-mediated resistance
4. Emerging Insights into Keratin 16 Expression during Metastatic Progression of Breast Cancer.
5. Multicenter Evaluation of Circulating Cell-Free DNA Extraction and Downstream Analyses for the Development of Standardized (Pre)analytical Work Flows
6. Gene expression and copy number profiling suggests the importance of allelic imbalance in 19p in asbestos-associated lung cancer
7. Pre-analytical factors affecting the establishment of a single tube assay for multiparameter liquid biopsy detection in melanoma patients
8. Multicenter evaluation of circulating cell-free DNA extraction and downstream analyses for the development of standardized (Pre)analytical work flows
9. P-207 Analysis of chemotherapy-induced subtype shifts in patient-derived tumoroids and parallels to functional in-vitro chemosensitivity testing in pancreatic ductal adenocarcinoma
10. Multicenter Evaluation of Circulating Cell-Free DNA Extraction and Downstream Analyses for the Development of Standardized (Pre)analytical Work Flows.
11. Circulating Tumor Cells as a Tumor Stage Independent Biomarker for Diagnosis, Prognosis, and Disease-monitoring in Pancreatic Ductal Adenocarcinoma
12. Pilot study on liquid biopsies: Are the site of blood draw and pancreatectomy affecting the detectability of CTCs and cfDNA?
13. VEGFR-2, CXCR-2 and PAR-1 germline polymorphisms as predictors of survival in pancreatic carcinoma
14. Expression of myeloid-specific genes in childhood acute lymphoblastic leukemia – a cDNA array study
15. Increased expression of high mobility group A proteins in lung cancer
16. L1CAM, INP10, P-cadherin, tPA and ITGB4 over-expression in malignant pleural mesotheliomas revealed by combined use of cDNA and tissue microarray
17. EPAC-lung: pooled analysis of circulating tumour cells in advanced non-small cell lung cancer
18. OC-0493 CTCs in patients with brain metastases under radiotherapy: do they indicate treatment response?
19. Detection of circulating tumor cells after cement augmentation of vertebral metastases
20. EPAC-Lung
21. EP-1708: Clinical relevance of DNA-damage response in metastatic breast and lung cancer under irradiation
22. Interplay of DNA repair and stem-like phenotype determines the sensitizing effect of CHK1, RAD51 and PARP1 inhibition in TNBC
23. Bedeutung von DNA Reparatur- und Stammzelleigenschaften für die Strahlensensitivierung bei Inhibition von CHK1-, RAD51- und PARP1 im TNBC
24. Circulating tumor cell dissemination after cement augmentation of vertebral metastases
25. Molecular characterization of breast cancer brain metastases and circulating tumor cells
26. Relevance of &bgr;ß-Gal-ß-GalNAc-containing O-glycans and the enzymes involved in their synthesis for vascular and lymphatic invasion and survival in breast cancer patients
27. Glutathione S-transferase GSTM3 and GSTP1 genotypes and larynx cancer risk
28. VEGFR-2, CXCR-2 und PAR-1 Polymorphismen als prognostische Marker für das Pankreaskarzinom
29. Die biologische Rolle des Adhäsionsmoleküls ALCAM in Mammakarzinom-Zelllinien und Tumoren
30. DNA copy number loss and allelic imbalance at 2p16 in lung cancer associated with asbestos exposure
31. Meta- and Pooled Analysis of GSTP1 Polymorphism and Lung Cancer: A HuGE-GSEC Review
32. Molecular Alterations at 9q33.1 and Polyploidy in Asbestos-Related Lung Cancer
33. 60 Asbestos-associatedmalignancies in the lung and pleura show distinct genetic aberrations
34. PD-024 Expression of High Mobility Group A proteins in lung cancer correlates with survival
35. Relevance of N-acetyltransferase 1 and 2 (NAT1, NAT2) genetic polymorphisms in non-small cell lung cancer susceptibility
36. CYP2D6 gene polymorphism in Caucasian smokers
37. hOGG1 polymorphism and loss of heterozygosity (LOH): Significance for lung cancer susceptibility in a caucasian population
38. Genetic polymorphisms in GSTs and individual susceptibility to lung cancer
39. Inherited metabolic capacity and susceptibility to isocyanate induced asthma
40. Role of arylamine N-acetyltransferase 1 and 2 (NAT1 and NAT2) genotypes in susceptibility to oral/pharyngeal and laryngeal cancers
41. 157P Soluble and EV-bound CD27 act as antagonistic biomarkers in patients with solid tumors undergoing immunotherapy.
42. The early evolution of the Southwest Swedish Gneiss Province: geochronological and isotopic evidence from southernmost Sweden
43. KRAS & GNAS mutations in cfDNA in patients with intraductal papillary mucinous neoplasms – an observational pilot-study regarding the risk of progression to pancreatic cancer.
44. P4D83 - Inherited metabolic capacity and susceptibility to isocyanate induced asthma
45. 21O EPAC-Lung: Pooled analysis of circulating tumor cells in advanced non-small cell lung cancer.
46. KRAS and GNAS mutations in cell-free DNA and in circulating epithelial cells in patients with intraductal papillary mucinous neoplasms-an observational pilot study.
47. Mutation analysis in individual circulating tumor cells depicts intratumor heterogeneity in melanoma.
48. Master corepressor inactivation through multivalent SLiM-induced polymerization mediated by the oncogene suppressor RAI2.
49. PIK3CA Hotspot Mutations in Saliva as a Diagnostic Marker in Oral Squamous Cell Carcinoma Patients.
50. HERC5 downregulation in non-small cell lung cancer is associated with altered energy metabolism and metastasis.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.